本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kiora Pharmaceuticals

2.47
-0.0900-3.52%
盘后:2.470.00000.00%16:10 EDT
成交量:2,974
成交额:7,441
市值:1,094.80万
市盈率:-1.02
高:2.55
开:2.55
低:2.47
收:2.56
52周最高:2.91
52周最低:1.76
股本:443.24万
流通股本:429.20万
量比:0.18
换手率:0.07%
股息:- -
股息率:- -
每股收益(TTM):-2.4100
每股收益(LYR):-2.6400
净资产收益率:-56.36%
总资产收益率:-21.92%
市净率:0.65
市盈率(LYR):-0.94

数据加载中...

2026/09/17

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/09/08

重要事件披露

Form 8-K - Current report
2026/08/19

重要事件披露

Form 8-K - Current report
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/10

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/07

重要事件披露

Form 8-K - Current report
2026/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/06/18

重要事件披露

Form 8-K - Current report
2026/06/11

重要事件披露

Form 8-K - Current report
2026/05/21

SEC问询函

Form CORRESP - Correspondence
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/08

重要事件披露

Form 8-K - Current report
2026/04/07

重要事件披露

Form 8-K - Current report
2026/04/02

重要事件披露

Form 8-K - Current report
2026/03/25

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/25

重要事件披露

Form 8-K - Current report